An overview of the clinical development of the 20-valent pneumococcal conjugate vaccine in adults.
Saved in:
| Title: | An overview of the clinical development of the 20-valent pneumococcal conjugate vaccine in adults. |
|---|---|
| Authors: | McElwee K; Pfizer Vaccines, Pfizer Inc, Collegeville, PA, USA., Vojicic J; Pfizer Vaccines, Pfizer Inc, Collegeville, PA, USA., Sabharwal C; Pfizer Vaccines, Pfizer Inc, Pearl River, NY, USA., Ginis J; Pfizer Vaccines, Pfizer Inc, Collegeville, PA, USA., Peng Y; Pfizer Vaccines, Pfizer Inc, Collegeville, PA, USA., Mircus G; Pfizer Vaccines, Pfizer Inc, Collegeville, PA, USA., Watson W; Pfizer Vaccines, Pfizer Inc, Collegeville, PA, USA., Anderson A; Pfizer Vaccines, Pfizer Inc, Pearl River, NY, USA. |
| Source: | Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2026 Dec; Vol. 22 (1), pp. 2616144. Date of Electronic Publication: 2026 Feb 09. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101572652 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2164-554X (Electronic) Linking ISSN: 21645515 NLM ISO Abbreviation: Hum Vaccin Immunother Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
